4hf5:L (PRO8) to (GLY77) CRYSTAL STRUCTURE OF FAB 8F8 IN COMPLEX A H2N2 INFLUENZA VIRUS HEMAGGLUTININ | VIRAL PROTEIN/IMMUNE SYSTEM, HEMAGGLUTININ, ANTIBODY, VIRAL RECEPTOR BINDING, ANTIGEN BINDING, SIALIC ACID, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3t0x:A (SER9) to (GLY77) FLUOROGEN ACTIVATING PROTEIN M8VLA4(S55P) IN COMPLEX WITH DIMETHYLINDOLE RED | IMMUNOGLOBULIN FOLD, FLUOROGEN ACTIVATION, DIMETHYLINDOLE RED, DYE- BINDING PROTEIN
3gbm:M (PRO8) to (GLY77) CRYSTAL STRUCTURE OF FAB CR6261 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ. | HEMAGGLUTININ, FAB, NEUTRALIZING ANTIBODIES, ANTIBODY, AVIAN FLU, ENVELOPE PROTEIN, FUSION PROTEIN, VIRAL PROTEIN - IMMUNE SYSTEM COMPLEX
3gbn:L (VAL11) to (GLY77) CRYSTAL STRUCTURE OF FAB CR6261 IN COMPLEX WITH THE 1918 H1N1 INFLUENZA VIRUS HEMAGGLUTININ | HEMAGGLUTININ, FAB, NEUTRALIZING ANTIBODIES, ANTIBODY, PANDEMIC FLU, CELL MEMBRANE, ENVELOPE PROTEIN, FUSION PROTEIN, GLYCOPROTEIN, LIPOPROTEIN, MEMBRANE, PALMITATE, TRANSMEMBRANE, VIRION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3tnn:L (SER10) to (GLY77) CRYSTAL STRUCTURE OF N5-I5 FAB, AN ADCC MEDIATING AND NON-NEUTRALIZING CD4I ANTI-HIV- 1 ANTIBODY. | ANTI-HIV-1 ENV ANTIBODY N5-I5, CD4I ANTIBODY, ADCC, HIV-1 ENV, IMMUNE SYSTEM
3tnn:B (SER10) to (GLY77) CRYSTAL STRUCTURE OF N5-I5 FAB, AN ADCC MEDIATING AND NON-NEUTRALIZING CD4I ANTI-HIV- 1 ANTIBODY. | ANTI-HIV-1 ENV ANTIBODY N5-I5, CD4I ANTIBODY, ADCC, HIV-1 ENV, IMMUNE SYSTEM
3tnn:D (SER10) to (GLY77) CRYSTAL STRUCTURE OF N5-I5 FAB, AN ADCC MEDIATING AND NON-NEUTRALIZING CD4I ANTI-HIV- 1 ANTIBODY. | ANTI-HIV-1 ENV ANTIBODY N5-I5, CD4I ANTIBODY, ADCC, HIV-1 ENV, IMMUNE SYSTEM
3tnn:F (SER10) to (GLY77) CRYSTAL STRUCTURE OF N5-I5 FAB, AN ADCC MEDIATING AND NON-NEUTRALIZING CD4I ANTI-HIV- 1 ANTIBODY. | ANTI-HIV-1 ENV ANTIBODY N5-I5, CD4I ANTIBODY, ADCC, HIV-1 ENV, IMMUNE SYSTEM
4yaq:L (SER9) to (GLY77) CRYSTAL STRUCTURE OF A COMPUTATIONALLY OPTIMIZED PG9 MUTANT | ANTIBODY, HIV, IMMUNE SYSTEM
4yaq:B (SER9) to (GLY77) CRYSTAL STRUCTURE OF A COMPUTATIONALLY OPTIMIZED PG9 MUTANT | ANTIBODY, HIV, IMMUNE SYSTEM
4m1d:L (SER9) to (GLY77) CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 CYCLIC PEPTIDE MN | HIV, V3 LOOP, ANTIBODY-ANTIGEN INTERACTIONS, ENVELOPE, IMMUNE SYSTEM
2ig2:L (PRO8) to (GLY76) DIR PRIMAERSTRUKTUR DES KRISTALLISIERBAREN MONOKLONALEN IMMUNOGLOBULINS IGG1 KOL. II. AMINOSAEURESEQUENZ DER L- KETTE, LAMBDA-TYP, SUBGRUPPE I (GERMAN) | IMMUNOGLOBULIN
5ado:L (SER9) to (GLY78) CRYSTAL STRUCTURE OF THE PARAOXON-MODIFIED A.17 ANTIBODY FAB FRAGMENT - LIGHT CHAIN S35R MUTANT | IMMUNE SYSTEM, ENZYME REPROGRAMMING, ANTIBODIES, IG SUPERFAMILY, IN SILICO ANTIBODY MATURATION
5adp:L (PRO8) to (GLY78) CRYSTAL STRUCTURE OF THE A.17 ANTIBODY FAB FRAGMENT - LIGHT CHAIN S35R MUTANT | IMMUNE SYSTEM, ENZYME REPROGRAMMING, ANTIBODIES, IG SUPERFAMILY, IN SILICO ANTIBODY MATURATION
4n0y:L (SER9) to (GLY77) STRUCTURE OF THE HEPATITIS C ENVELOPE GLYCOPROTEIN E1 ANTIGENIC REGION 314-324 BOUND TO THE CROSS-NEUTRALIZING ANTIBODY IGH526 | IMMUNOGLOBULIN FOLD, AMIDATED C-TERMINUS, IMMUNE SYSTEM
4n1h:B (GLN3) to (ASN84) STRUCTURE OF A SINGLE-DOMAIN CAMELID ANTIBODY FRAGMENT CAB-F11N IN COMPLEX WITH THE BLAP BETA-LACTAMASE FROM BACILLUS LICHENIFORMIS | IMMUNOGLOBULIN FOLD, ANTIGEN BINDING, HYDROLASE-IMMUNE SYSTEM COMPLEX
2jb6:A (ALA8) to (GLY79) FAB FRAGMENT IN COMPLEX WITH SMALL MOLECULE HAPTEN, CRYSTAL FORM-2 | CDR, TSC, FAB, HUCAL, FLUORESCENT DYE, IMMUNOGLOBULIN DOMAIN, ANTIBODY FRAGMENT, DIAGNOSTIC IMAGING, IMMUNE SYSTEM
2xza:L (PRO8) to (GLY78) CRYSTAL STRUCTURE OF RECOMBINANT A.17 ANTIBODY FAB FRAGMENT | IMMUNE SYSTEM
2xzc:L (PRO8) to (GLY78) CRYSTAL STRUCTURE OF PHOSPHONATE-MODIFIED RECOMBINANT A.17 ANTIBODY FAB FRAGMENT | IMMUNE SYSTEM
3zl4:L (SER9) to (GLY78) ANTIBODY STRUCTURAL ORGANIZATION: ROLE OF KAPPA - LAMBDA CHAIN CONSTANT DOMAIN SWITCH IN CATALYTIC FUNCTIONALITY | IMMUNE SYSTEM
5c2b:L (ALA8) to (GLY79) ANTI-CXCL13 PARENTAL SCFV - 3B4 | ANTI-CXCL13, SCFV, IMMUNE SYSTEM
5c6w:H (ALA1008) to (GLY1079) ANTI-CXCL13 SCFV - E10 | ANTI-CXCL13, SCFV, IMMUNE SYSTEM
5c6w:J (ALA1008) to (GLY1079) ANTI-CXCL13 SCFV - E10 | ANTI-CXCL13, SCFV, IMMUNE SYSTEM
5cbe:B (ALA8) to (GLY77) E10 IN COMPLEX WITH CXCL13 | ANTI-CXCL13, E10, SCFV, IMMUNE SYSTEM
5cbe:D (GLN1) to (GLY77) E10 IN COMPLEX WITH CXCL13 | ANTI-CXCL13, E10, SCFV, IMMUNE SYSTEM
4osu:L (PRO8) to (GLY78) CRYSTAL STRUCTURE OF HCMV GB-NEUTRALIZING SM5-1 FAB FRAGMENT | IMMUNOGLOBULIN, IMMUNE RESPONSE, HCMV NEUTRALIZATION, HCMV GLYCOPROTEIN B, IMMUNE SYSTEM
4aiz:B (SER9) to (GLY76) CRYSTALLOGRAPHIC STRUCTURE OF 3MJL2 FROM THE GERMINAL LINE LAMBDA 3 | IMMUNE SYSTEM, AMYLOIDOSIS
4aiz:D (PRO8) to (GLY76) CRYSTALLOGRAPHIC STRUCTURE OF 3MJL2 FROM THE GERMINAL LINE LAMBDA 3 | IMMUNE SYSTEM, AMYLOIDOSIS
3lmj:L (SER9) to (GLY78) STRUCTURE OF HUMAN ANTI HIV 21C FAB | IMMUNOGLOBULIN, IMMUNE SYSTEM
4qhl:B (SER9) to (GLY77) I3.2 (UNBOUND) FROM CH103 LINEAGE | FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM
4qhl:D (SER9) to (GLY77) I3.2 (UNBOUND) FROM CH103 LINEAGE | FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM
3mcg:1 (PCA1) to (SER78) THREE-DIMENSIONAL STRUCTURE OF A LIGHT CHAIN DIMER CRYSTALLIZED IN WATER. CONFORMATIONAL FLEXIBILITY OF A MOLECULE IN TWO CRYSTAL FORMS | IMMUNOGLOBULIN
3muh:L (ALA8) to (GLY77) CRYSTAL STRUCTURE OF PG9 LIGHT CHAIN | PG9, HIV, IMMUNE SYSTEM
5f6h:J (PRO8) to (GLY79) CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE | FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM
3c2a:M (SER9) to (GLY77) ANTIBODY FAB FRAGMENT 447-52D IN COMPLEX WITH UG1033 PEPTIDE | ANTIBODY FAB HIV-1 PEPTIDE, ENVELOPE PROTEIN, IMMUNE SYSTEM
4rfo:L (SER9) to (GLY77) CRYSTAL STRUCTURE OF THE ADCC-POTENT ANTIBODY N60-I3 FAB IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48U1 | HIV-1 GP120, CLADE A/E 93TH057, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM-INHIBITOR COMPLEX
4dqo:L (SER9) to (GLY77) CRYSTAL STRUCTURE OF PG16 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109 | IMMUNOGLOBULIN, IMMUNE RECOGNITION, IMMUNE SYSTEM, GLYCAN, HIV-1, V1V2, ENVELOPE GLYCOPROTEIN
4unv:A (SER9) to (GLY79) COVALENT DIMER OF LAMBDA VARIABLE DOMAINS | IMMUNE SYSTEM, BENCE-JONES, IMMUNOGLOBULIN, AMYLOID
4eow:L (SER9) to (GLY78) CRYSTAL STRUCTURE OF A DISEASE-ASSOCIATED ANTI-HUMAN GM-CSF AUTOANTIBODY MB007 | IMMUNSYSTEM, ALPHA-HELICAL STRETCH IN CDR3-H, PROTEIN-DOCKING, IMMUNOGLOBULIN IGG1 (LAMBDA), AUTOANTIBODY CAUSING PAP, GM-CSF, IMMUNE SYSTEM
4f58:M (SER9) to (GLY77) FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L3 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT | IG, ANTIBODY, GP120, IMMUNE SYSTEM
4f58:N (LEU4) to (GLY77) FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L3 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT | IG, ANTIBODY, GP120, IMMUNE SYSTEM
4f58:O (ALA8) to (GLY77) FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L3 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT | IG, ANTIBODY, GP120, IMMUNE SYSTEM
3u2s:L (SER9) to (GLY77) CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109 | GREEK KEY, IMMUNOGLOBULIN, IMMUNE RECOGNITION, IMMUNE SYSTEM
3u2s:B (ALA8) to (GLY77) CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109 | GREEK KEY, IMMUNOGLOBULIN, IMMUNE RECOGNITION, IMMUNE SYSTEM
4nki:L (ALA8) to (GLY79) CRYSTAL STRUCTURE OF A FAB | NONOCLONAL ANTIBODY, IMMUNOGLOBULIN, ANTIBODY, PD-L1, SOLUBLE PROTEIN, CYTOKINE
4rav:B (ALA135) to (GLY206) CRYSTAL STRUCTURE OF SCFVC4 IN COMPLEX WITH THE FIRST 17 AA OF HUNTINGTIN | IMMUNOGLOBULIN FOLD, IMMUNITY, 1-17 RESIDUES OF HUNTINGTIN, IMMUNE SYSTEM-APOPTOSIS COMPLEX